Business

Apollo Endosurgery Ann $2five Million Equity Financing, solar loan modification and second quarter commercial update

AUSTIN, TX /ACCESSWIRE / July 20, 2020 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced that it has signed final agreements for $2 five million in equity financing. Simultaneously

Apollo Endosurgery Ann $2five Million Equity Financing, solar loan modification and second quarter commercial update Read More »